Form D · Biotechnology

Compass Therapeutics LLC

Cambridge, MA · CIK 0001610824

Offering snapshot reported Jul 16, 2018 · SEC filing

Reported sold
$110M
Offering amount: $170M
Investors reported
20
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 17, 2015
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$55.1M$110MJul 1, 2015: $15,977,535.00Jul 1, 2015Sep 21, 2016: $45,977,738.00Sep 21, 2016Jul 16, 2018: $110,191,606.00Jul 16, 2018

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$45,977,738 → $110,191,606
  • Reported investors17 → 20

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 16, 2018Amendment$110,191,606$64,213,868vs Sep 21, 201620SEC filing
Jan 8, 2018Initial$21,847,787No comparison14SEC filing
Sep 21, 2016Amendment$45,977,738$30,000,203vs Jul 1, 201517SEC filing
Jul 1, 2015Initial$15,977,535No comparison11SEC filing
May 28, 2015Amendment$575,000$100,000vs Jun 13, 20144SEC filing
Jun 13, 2014Initial$475,000No comparison3SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-242888

Source: Form D, filed Jul 16, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Errik Anderson Director, Promoter
Timothy Anderson Director
Ben Auspitz Director
Damon Banks Executive
Vered Bisker Leib Executive
Piotr Bobrowicz Executive
Will Eden Director
Philip Ferneau Director
Carl Gordon Director
Jeb Ledell Executive
Sara Mannle Executive
Thomas J. Schuetz Director, Executive, Promoter
Jonathan Sheller Director, Executive
Stephen Squinto Director
Steven Squinto Director
Bruce Steel Director
Schuetz Thomas Director, Executive
Steve Tregay Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
245 First Street
Cambridge, MA, 02142